Astrazeneca files suit against Dr. Reddy’s Laboratories over one patent related to a pharmaceutical composition in unit dose form suitable for oral administration to a patient. 4/21, District of New Jersey, 3:2011cv02317.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.
Related News
